Global biopharmaceutical company Gilead Sciences Inc. (Nasdaq: GILD) is closing its office in Seattle and laying off 72 ...

As of September 30, 2024, Fortress' consolidated cash and cash equivalents totaled $58.9 million, compared to $76.2 million ...

BAY HARBOR ISLAND, Fla. (AP) — BAY HARBOR ISLAND, Fla. (AP) — Fortress Biotech Inc. (FBIO) on Thursday reported a loss of $12.9 million in its third quarter. On a per-share basis, the Bay Harbor ...

Sensei Biotherapeutics is laying off 46% of its workforce as the cancer-focused biotech looks to preserve cash to take its ...

On STAT's podcast, hear about what happened with AbbVie's schizophrenia drug, Amgen's obesity drug and what might happen at ...

A Hong Kong biotech company said its therapeutic HIV vaccine showed “promising” results in a recent clinical trial, taking it ...

After a research note raised potential safety concerns with Amgen's lead obesity candidate, the company defended its drug and ...

With the new operations site and logistics center in Sydney, “Australian researchers and biotech companies will no longer ...

Germany’s Evotec SE is attracting potential takeover interest from Nasdaq-listed biotech firm Halozyme Therapeutics Inc., ...

Successfully navigating a drug development cycle is a major undertaking. On average, the sequence takes over a decade to ...

Roughly a year ago, Gilead Sciences revealed that it was laying off about 7% of Kite Pharma’s workforce in a bid to refresh ...

ALBANY – Albany State University has announced the launch of a new Master of Science in Integrated Biotechnology program, set to begin in spring 2025. This degree is designed to prepare students for a ...